Johannesburg, Friday, 09 October 2026. In line with the provisions of the 2018 Harmony Deferred Share Plan, executive directors, company secretary and prescribed officers of Harmony were awarded deferred shares on 18 September 2026 based on the 5-day volume weighted average price of R323.28 per ordinary share and accepted these awards on 8 October 2026. In addition, in compliance with paragraphs 6.77 to 6.80 of the JSE Listings Requirements, dealings in securities by executive directors, company secretary and prescribed officers are disclosed.

The following transactions are disclosed in relation to the deferred share awards:

1.	Name of director:	BB Nel (Group Chief Executive Officer)
	Nature of transaction:	Off market award of deferred shares
	Periods of vesting:	Deferred shares vest in five equal tranches over a five-year period
	Class of securities:	Deferred ordinary shares
	Number of deferred shares awarded:	63 271
	Total value of shares awarded:	R20 454 294.96
	Nature and extent of director’s interest:	Direct beneficial

2.	Name of director:	BP Lekubo (Financial Director)
	Nature of transaction:	Off market award of deferred shares
	Periods of vesting:	Deferred shares vest in five equal tranches over a five-year period
	Class of securities:	Deferred ordinary shares
	Number of deferred shares awarded:	38 837
	Total value of shares awarded:	R12 555 395.34
	Nature and extent of director’s interest:	Direct beneficial

3.	Name of director:	HE Mashego (Executive Director)
	Nature of transaction:	Off market award of deferred shares
	Periods of vesting:	Deferred shares vest in five equal tranches over a five-year period
	Class of securities:	Deferred ordinary shares
	Number of deferred shares awarded:	28 871
	Total value of shares awarded:	R9 333 521.37
	Nature and extent of director’s interest:	Direct beneficial

4.	Name of prescribed officer:	AJ Boshoff
	Nature of transaction:	Off market award of deferred shares
	Periods of vesting:	Deferred shares vest in five equal tranches over a five-year period
	Class of securities:	Deferred ordinary shares
	Number of deferred shares awarded:	25 869
	Total value of shares awarded:	R8 363 022.30
	Nature and extent of prescribed officer’s interest:	Direct beneficial

5.	Name of prescribed officer:	AZ Buthelezi
	Nature of transaction:	Off market award of deferred shares
	Periods of vesting:	Deferred shares vest in five equal tranches over a five-year period
	Class of securities:	Deferred ordinary shares
	Number of deferred shares awarded:	27 173
	Total value of shares awarded:	R8 784 491.21
	Nature and extent of prescribed officer’s interest:	Direct beneficial

6.	Name of prescribed officer:	U Govender
	Nature of transaction:	Off market award of deferred shares
	Periods of vesting:	Deferred shares vest in five equal tranches over a five-year period
	Class of securities:	Deferred ordinary shares
	Number of deferred shares awarded:	27 173
	Total value of shares awarded:	R8 784 491.21
	Nature and extent of prescribed officer’s interest:	Direct beneficial

7.	Name of prescribed officer:	FS Masemula
	Nature of transaction:	Off market award of deferred shares
	Periods of vesting:	Deferred shares vest in five equal tranches over a five-year period
	Class of securities:	Deferred ordinary shares
	Number of deferred shares awarded:	31 362
	Total value of shares awarded:	R10 138 786.79
	Nature and extent of prescribed officer’s interest:	Direct beneficial

8.	Name of prescribed officer:	MP van der Walt
	Nature of transaction:	Off market award of deferred shares
	Periods of vesting:	Deferred shares vest in five equal tranches over a five-year period
	Class of securities:	Deferred ordinary shares
	Number of deferred shares awarded:	27 173
	Total value of shares awarded:	R8 784 491.21
	Nature and extent of prescribed officer’s interest:	Direct beneficial

9.	Name of prescribed officer:	JJ van Heerden
	Nature of transaction:	Off market award of deferred shares
	Periods of vesting:	Deferred shares vest in five equal tranches over a five-year period
	Class of securities:	Deferred ordinary shares
	Number of deferred shares awarded:	38 465
	Total value of shares awarded:	R12 435 114.79
	Nature and extent of prescribed officer’s interest:	Direct beneficial

10.	Name of company secretary:	SS Mohatla
	Nature of transaction:	Off market award of deferred shares
	Periods of vesting:	Deferred shares vest in three equal tranches over a three-year period
	Class of securities:	Deferred ordinary shares
	Number of deferred shares awarded:	13 537
	Total value of shares awarded:	R4 376 393.72
	Nature and extent of company secretary’s interest:	Direct beneficial

Prior clearance was obtained in respect of the above dealings by the executive directors, company secretary and prescribed officers.

Ends.

For more details contact:

Shela Mohatla
Executive: Group Company Secretary
+27 (0) 71 571 4249
Johannesburg, South Africa

9 October 2026

Sponsor:
J.P. Morgan Equities South Africa Proprietary Limited